Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ذي بوتس كومبانيبي بي ال سيfiledCriticalذي بوتس كومبانيبي بي ال سي
Priority to JO19951825ApriorityCriticalpatent/JO1825B1/en
Application grantedgrantedCritical
Publication of JO1825B1publicationCriticalpatent/JO1825B1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Compounds of formula I And pharmaceutical acceptable salts thereof in which R1 represents a C1-6 alkyl group optionally substituted by one or more hydroxyl groups, R2 represent a C2-6 alkoxycarbonyl groups, and R3, R4.R5 independently represent hydrogen, halo, a halogenated C1-6 alkyl group in which at least one halogen atom is attached to the carbon atom which is attached to the naphthyridine ring, or a halogenated C1-6 alkyl group in which at least one halogen atom is attached to the carbon atom which is attached to the oxygen atom of the alkoxy group, provided that the least one of R3, R4.R5 represents a group other than hydrogen, are disclosed which are group other than hydrogen, are disclosed which are antirheumatic agents, compositions containing theses compounds and processes to make them are also disclosed.
Phenyl carboxamide-isoxazole-derivatives and salts, process for their preparation, their use as pharmaceuticals, and pharmaceutical compositions containing them.
3,4-Di-(hydro)-2H,6H-pyrimido not 2,1-b not 1,3 thiazine derivatives and 1,2,3,4-tetra-(hydro)-pyrimidin-2-thiones, process for their preparation and medicament containing them